Clinical Trial: Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy
Brief Summary: The purpose of this study is to determine the efficacy in the use of topical Squalamine Lactate Ophthalmic Solution, 0.2% in the treatment of retinal neovascularization resulting from proliferative diabetic retinopathy.
Detailed Summary:
Sponsor: Elman Retina Group
Current Primary Outcome: Proportion with complete regression of neovascularization on fundus photography at one month [ Time Frame: 1 Month ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Mean Change in Visual Acuity from Baseline to 5 Months [ Time Frame: 5 months ]
Original Secondary Outcome: Same as current
Information By: Elman Retina Group
Dates:
Date Received: January 14, 2013
Date Started: February 2013
Date Completion:
Last Updated: February 9, 2015
Last Verified: February 2015